User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Search

Displaying 9 results.
    • Speech
    SUCCESSFUL STEROID REPLACEMENT IN ANCA-ASSOCIATED VASCULITIS WITH C5A RECEPTOR INHIBITOR CCX168 IN PHASE 2 RANDOMISED TRIAL (CLEAR)
    Jayne, David Bruchfeld, Annette Harper, Lorraine Schaier, Matthias Venning, Michael Hamilton, Patrick Burst, Volker Grundman, Franziska Jadoul, Michel[UCL] Szombati, Istvan Tesar, Vladimir Segelmark, Mårten Potarca, Antonia Schall, Thomas J. Bekker, Pirow (2016) 53rd ERA-EDTA Congress — Vienna, Austria
    • Journal article
    The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.
    de Zeeuw, Dick Bekker, Pirow Henkel, Elena Hasslacher, Christopher Gouni-Berthold, Ioanna Mehling, Heidrun Potarca, Antonia Tesar, Vladimir Heerspink, Hiddo J Lambers Schall, Thomas J CCX140-B Diabetic Nephropathy Study Group Jadoul, Michel[UCL] (2015) The lancet. Diabetes & endocrinology — Vol. 3, no.9, p. 687-696 (2015)
    • Speech
    Rapid onset of action of orally administered C5aR Inhibitor CCX168 in randomized clinical trial in ANCA-associated vasculitis (CLEAR)
    Tesar, Vladimir Jayne, David RW Bruchfeld, Annette Harper, Lorraine Schaier, Matthias Hamilton, Patrick Burst, Volker Rolf Grundmann, Franziska Jadoul, Michel[UCL] Szombati, Istvan Potarca, Antonia Schall, Thomas J Bekker, Pirow (2016) ASN Renal Week — Chicago, IL
    • Journal article
    Building a network of ADPKD reference centres across Europe: the EuroCYST initiative
    Petzold, Katja Gansevoort, Ron T. Ong, Albert C. M. Devuyst, Olivier[UCL] Rotar, Laure Eckardt, Kai-Uwe Kottgen, Anna Pirson, Yves[UCL] Remuzzi, Giuseppe Sandford, Richard Tesar, Vladimir Ecder, Tevfik Chaveau, Dominique Torra, Roser Budde, Klemens Le Meur, Yannick Wuthrich, Rudolf P. Serra, Andreas L. (2014) Nephrology, Dialysis, Transplantation — Vol. 29, no. Suppl 4, p. iv26-iv32 (2014)
    • Journal article
    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
    Fanouriakis, Antonis Kostopoulou, Myrto Alunno, Alessia Aringer, Martin Bajema, Ingeborg Boletis, John N Cervera, Ricard Doria, Andrea Gordon, Caroline Govoni, Marcello Houssiau, Frédéric[UCL] Jayne, David Kouloumas, Marios Kuhn, Annegret Larsen, Janni L Lerstrøm, Kirsten Moroni, Gabriella Mosca, Marta Schneider, Matthias Smolen, Josef S Svenungsson, Elisabet Tesar, Vladimir Tincani, Angela Troldborg, Anne van Vollenhoven, Ronald Wenzel, Jörg Bertsias, George Boumpas, Dimitrios T (2019) Annals of the Rheumatic Diseases — Vol. 78, no. 6, p. 736-745 (2019)
    • Journal article
    Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
    Mackay, Meggan Dall'Era, Maria Fishbein, Joanna Kalunian, Kenneth Lesser, Martin Sanchez-Guerrero, Jorge Levy, Deborah M Silverman, Earl Petri, Michelle Arriens, Cristina Lewis, Edmund J Korbet, Stephen M Conti, Fabrizio Tesar, Vladimir Hruskova, Zdenka Borba, Eduardo F Bonfa, Eloisa Chan, Tak Mao Rathi, Manish Gupta, K L Jha, Vivekanand Hasni, Sarfaraz West, Melissa R Solomons, Neil Houssiau, Frédéric[UCL] Romero-Diaz, Juanita Mejia-Vilet, Juan Rovin, Brad H (2019) Arthritis & rheumatology — Vol. 71, no.3, p. 411-419 (2019)
    • Journal article
    2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis, Antonis Kostopoulou, Myrto Cheema, Kim Anders, Hans-Joachim Aringer, Martin Bajema, Ingeborg Boletis, John Frangou, Eleni Houssiau, Frédéric[UCL] Hollis, Jane Karras, Adexandre Marchiori, Francesca Marks, Stephen D Moroni, Gabriella Mosca, Marta Parodis, Ioannis Praga, Manuel Schneider, Matthias Smolen, Josef S Tesar, Vladimir Trachana, Maria van Vollenhoven, Ronald F Voskuyl, Alexandre E Teng, Y K Onno van Leew, Bernadette Bertsias, George Jayne, David Boumpas, Dimitrios T (2020) Annals of the rheumatic diseases — Vol. 79, no.6, p. 713-723 (2020)
    • Journal article
    Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    Fellström, Bengt C. Jardine, Alan G. Schmieder, Roland E. Holdaas, Hallvard Bannister, Kym Beutler, Jaap Chae, Dong-Wan Chevaile, Alejandro Cobbe, Stuart M. Grönhagen-Riska, Carola De Lima, José J. Lins, Robert Mayer, Gert McMahon, Alan W. Parving, Hans-Henrik Remuzzi, Giuseppe Samuelsson, Ola Sonkodi, Sandor Sci, D. Süleymanlar, Gultekin Tsakiris, Dimitrios Tesar, Vladimir Todorov, Vasil Wiecek, Andrzej Wüthrich, Rudolf P. Gottlow, Mattis Johnsson, Eva Zannad, Faiez AURORA STUDY GROUP Pirson, Yves[UCL] (2009) New England Journal of Medicine — Vol. 360, no. 14, p. 1395-1407 (2009)
    • Journal article
    Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
    Barratt, Jonathan Lafayette, Richard Kristensen, Jens Stone, Andrew Cattran, Daniel Floege, Jürgen Tesar, Vladimir Trimarchi, Hernán Zhang, Hong Eren, Necmi Paliege, Alexander Rovin, Brad H NefIgArd Trial Investigators Demoulin, Nathalie[UCL] (2023) Kidney international — Vol. 103, no. 2, p. 391-402 (2023)